Literature DB >> 23937984

Pregnancies in patients with chronic myeloid leukemia treated with tyrosine kinase inhibitor.

Li Zhou1, Jian-Hua You, Wen Wu, Jun-Min Li, Zhi-Xiang Shen, Ai-Hua Wang.   

Abstract

We presented our experience in chronic myeloid leukemia (CML) patients who conceived children and/or became pregnant while receiving tyrosine kinase inhibitor (TKI). Among 7 male patients, 7 pregnancies resulted in the birth of 7 healthy babies. Among 18 female patients, 8 ended in elective abortion; 3 had spontaneous abortion, and 7 carried to term, resulting in the birth of 8 healthy babies. All children have normal growth and development. All patients remain in TKI therapy and in good response. It is suggested that female patients are advised to practice adequate contraception. No special precautions apply for male patients receiving TKI.
Copyright © 2013 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Chronic myeloid leukemia; Imatinib; Nilotinib; Pregnancy

Mesh:

Substances:

Year:  2013        PMID: 23937984     DOI: 10.1016/j.leukres.2013.07.020

Source DB:  PubMed          Journal:  Leuk Res        ISSN: 0145-2126            Impact factor:   3.156


  11 in total

Review 1.  [Andrological consultation in new systemic oncological therapies with small molecules].

Authors:  Till Weidner; Uwe Paasch; Sonja Grunewald
Journal:  Hautarzt       Date:  2018-12       Impact factor: 0.751

Review 2.  Gastrointestinal stromal tumors during pregnancy: a systematic review of an uncommon but treatable malignancy.

Authors:  G Zarkavelis; D Petrakis; N Pavlidis
Journal:  Clin Transl Oncol       Date:  2015-06-09       Impact factor: 3.405

3.  The impact of dasatinib on pregnancy outcomes.

Authors:  Jorge E Cortes; Elisabetta Abruzzese; Ekaterina Chelysheva; Mausumee Guha; Nicola Wallis; Jane F Apperley
Journal:  Am J Hematol       Date:  2015-10-12       Impact factor: 10.047

Review 4.  Fertility considerations in targeted biologic therapy with tyrosine kinase inhibitors: a review.

Authors:  Anupama Rambhatla; Michael R Strug; Jessica Garcia De Paredes; Marcos I Cordoba Munoz; Mili Thakur
Journal:  J Assist Reprod Genet       Date:  2021-04-07       Impact factor: 3.357

5.  Chronic Myeloid Leukemia and Cesarean Section: The Anesthesiologist's Point of View.

Authors:  Houssam Rebahi; Mourad Ait Sliman; Ahmed-Rhassane El Adib
Journal:  Case Rep Obstet Gynecol       Date:  2018-09-18

Review 6.  Outcome of 3 pregnancies in a patient with chronic myeloid leukemia who received 3 types of tyrosine kinase inhibitors each in different pregnancy: follow-up of the case with a review of published reports.

Authors:  Hussain Alizadeh; Hassan Jaafar; Béla Kajtár
Journal:  Ann Saudi Med       Date:  2015 Nov-Dec       Impact factor: 1.526

7.  [Fertility and disease outcomes in patients with chronic myeloid leukemia].

Authors:  X L Dou; Y Z Qin; H X Shi; Y Y Lai; Y Hou; X J Huang; Q Jiang
Journal:  Zhonghua Xue Ye Xue Za Zhi       Date:  2019-12-14

Review 8.  Tyrosine kinase inhibitors and pregnancy.

Authors:  Elisabetta Abruzzese; Malgorzata Monika Trawinska; Alessio Pio Perrotti; Paolo De Fabritiis
Journal:  Mediterr J Hematol Infect Dis       Date:  2014-04-07       Impact factor: 2.576

9.  Gonadotoxic Effects of Nilotinib in Chronic Myeloid Leukemia Treatment Dose in a Mouse Model.

Authors:  Güldane Cengiz Seval; Sinan Özkavukçu; Murat Seval; Meltem Aylı
Journal:  Turk J Haematol       Date:  2016-07-28       Impact factor: 1.831

10.  Pregnancy Outcomes in Chronic Myeloid Leukemia: A Single Center Experience.

Authors:  Irappa Madabhavi; Malay Sarkar; Mitul Modi; Nagaveni Kadakol
Journal:  J Glob Oncol       Date:  2019-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.